Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2016-04-27 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
第八届董事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the board of directors of 马应龙药业集团股份有限公司 regarding resolutions passed at the 13th meeting of the 8th board. It includes approval of the 2016 Q1 report, adjustments to director remuneration, nomination of candidates for the 9th board, and scheduling of the 2015 annual general meeting. The document contains voting results and detailed information about board candidates, which is typical of board meeting resolutions and management/board information disclosures. It does not contain the full quarterly report or financial statements, but rather announces board decisions and changes. Therefore, it fits best under Board/Management Information (MANG). The document length is 2356 characters, which is relatively short and consistent with an announcement rather than a full report.
2016-04-27 Chinese
独立董事候选人声明（黄艳华）
Board/Management Information Classification · 95% confidence The document is a declaration by an independent director candidate, Huang Yanhua, confirming qualifications, independence, and compliance with relevant laws and regulations for serving as an independent director at Mayinglong Pharmaceutical Group Co., Ltd. It includes detailed statements about eligibility, independence criteria, and commitments. There is no financial data, no report or results, no meeting minutes, no voting results, no legal proceedings, no capital changes, and no earnings information. This document is a formal announcement related to board/management information, specifically about a board candidate's declaration. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management nomination and qualifications, not a report or announcement of a report.
2016-04-27 Chinese
独立董事候选人声明（赵曼）
Board/Management Information Classification · 95% confidence The document is a declaration by an independent director candidate, Zhao Man, confirming qualifications, independence, and compliance with relevant laws and regulations for serving as an independent director of Mayinglong Pharmaceutical Group Co., Ltd. It includes detailed statements about legal qualifications, independence criteria, and commitments to fulfill duties. There is no financial data, no report or announcement of financial results, no voting results, no management changes, no legal proceedings, or other typical financial or regulatory filings. This document is a formal declaration related to board/management information, specifically about a director candidate's qualifications and independence. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on director candidacy declaration, not a report or announcement of a report, so it is not RPA or RNS. Confidence is high due to clear content and context.
2016-04-27 Chinese
关于召开2015年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2015 Annual General Meeting (AGM) of the company 马应龙药业集团股份有限公司. It includes information about the meeting date, voting procedures, agenda items including the 2015 annual report and financial statements, election of board members, and instructions for shareholders. The document is not the annual report itself but a formal announcement and notice for the AGM, including proxy forms and voting instructions. It does not contain financial statements or management discussion but focuses on the meeting logistics and agenda. Therefore, it fits the category of AGM Information (AGM-R). The document length (5440 characters) and content confirm it is a meeting notice rather than a report or voting results announcement.
2016-04-27 Chinese
独立董事提名人声明
Board/Management Information Classification · 95% confidence The document is a nomination statement for independent directors of a company's board, detailing qualifications, compliance with laws and regulations, and independence criteria. It does not contain financial data, audit results, or report publication information. It is related to board/management information, specifically about board member nominations. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and focused on nomination declarations, not a full report or announcement of voting results.
2016-04-27 Chinese
2016年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2016 First Quarter Report" of the company 马应龙药业集团股份有限公司. It contains detailed financial data including balance sheets, profit and loss items, cash flow statements, and explanations of financial changes for the quarter ending March 31, 2016. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content includes unaudited quarterly financial statements and management explanations, which fits the definition of an Interim / Quarterly Report (IR). There is no indication that this is an announcement of a report or a certification letter, so it is not RPA or RNS. Therefore, the document is classified as an Interim / Quarterly Report (IR).
2016-04-27 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.